Kim T. Le

Counsel
San Francisco
Tel: +1 415 738 5706
Overview
Kim T. Le is a corporate counsel and a member of the firm’s Healthcare & Life Sciences Group. She is also active in the firm’s Data Strategy ... Read Full Biography

Publications

  • California Lawmakers Target Private Equity and Hedge Fund Investment in Healthcare Facilities
    23 February 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Kevin Rinker
    ,
    Kim T. Le
    ,
    Michael L. Cederblom
    ,
    Hannah R. Levine
  • California’s Office of Health Care Affordability Finalizes Health Care Transaction Notice Regulations
    12 January 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Michael Diz
    ,
    Spencer K. Gilbert
    ,
    Kevin Rinker
    ,
    Matthew M. Delja
    ,
    Kim T. Le
    ,
    Michael L. Cederblom
    ,
    Hannah R. Levine
  • Top 10 Healthcare and Life Sciences Issues to Watch in 2024
    4 January 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Ted Hassi
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Michael Schaper
    ,
    Erica S. Weisgerber
    ,
    Kim T. Le
    ,
    Melissa Runsten
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Ilya Balabanovsky
    ,
    Michael L. Cederblom
    ,
    Margaret Howard
    ,
    Chaim Lapp
    ,
    Hannah R. Levine
    ,
    Zoe Jacoby
    ,
    Kaitlyn McGill
  • CMS Announces First Ten Medicare Part D Drugs Subject to Price Negotiations
    6 October 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Michael L. Cederblom
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
  • California Regulators Publish Draft Regulations on Health Care Pre-Transaction Notice Requirements
    29 August 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Kevin Rinker
    ,
    Kim T. Le
    ,
    Michael L. Cederblom
    ,
    Hannah R. Levine
  • California Seeks to Increase Healthcare Workers’ Minimum Wage to $25/hour
    21 August 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Meir D. Katz
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
    ,
    Michael L. Cederblom
  • Artificial Intelligence in Healthcare: Balancing Risks and Rewards
    31 July 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Avi Gesser
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Caroline P. Geiger
    ,
    Kim T. Le
    ,
    Tigist Kassahun
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
    ,
    Mengyi Xu
    ,
    Michael L. Cederblom
  • FDA Guidance Offers Additional Clarity for Decentralized Clinical Trials
    30 May 2023
    Andrew L. Bab
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
    ,
    Michael L. Cederblom
  • Legal Dispute Surrounding Abortion Pill Has Significant Implications for Broader Healthcare Industry
    9 May 2023
    Andrew L. Bab
    ,
    Maura Kathleen Monaghan
    ,
    Paul D. Rubin
    ,
    Shannon Rose Selden
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Prakriti Luthra
    ,
    Melissa Runsten
  • New York Seeks Review and Approval Authority over Certain Healthcare Transactions
    7 March 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Kim T. Le
    ,
    Hannah R. Levine
    ,
    Michael L. Cederblom
  • Proceed with Caution: Online Tracking Technologies Pose HIPAA Compliance Risks
    2 March 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Kim T. Le
    ,
    Hannah R. Levine
    ,
    Michael L. Cederblom
  • Private Equity Report: 2023 Outlook
    January 2023
    Catherine Amirfar
    ,
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Jason Auerbach
    ,
    Dominic Blaxill
    ,
    Ezra Borut
    ,
    Kara Brockmeyer
    ,
    Geoffrey P. Burgess
    ,
    Lawrence K. Cagney
    ,
    Andrew J. Ceresney
    ,
    Jennifer L. Chu
    ,
    Alexander R. Cochran
    ,
    Eric Dinallo
    ,
    Christopher Dortschy
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Jyotin Hamid
    ,
    Ted Hassi
    ,
    Morgan J. Hayes
    ,
    Gareth Hughes
    ,
    Peter J. Irwin
    ,
    Mark Johnson
    ,
    Eric T. Juergens
    ,
    Rafael Kariyev
    ,
    Meir D. Katz
    ,
    Satish M. Kini
    ,
    M. Natasha Labovitz
    ,
    Henry Lebowitz
    ,
    Maurizio Levi-Minzi
    ,
    Andrew M. Levine
    ,
    Sidney P. Levinson
    ,
    Jonathan F. Lewis
    ,
    Marilyn A. Lion
    ,
    Timothy McIver
    ,
    John (Jay) Neukom
    ,
    Benjamin R. Pedersen
    ,
    Marc Ponchione
    ,
    Nicholas F. Potter
    ,
    Ryan T. Rafferty
    ,
    Julie M. Riewe
    ,
    Samantha J. Rowe
    ,
    Paul D. Rubin
    ,
    Scott B. Selinger
    ,
    Jane Shvets
    ,
    Steven J. Slutzky
    ,
    Patricia Volhard
    ,
    Erica S. Weisgerber
    ,
    Barbara N. Barath
    ,
    Alison E. Buckley-Serfass
    ,
    Zhiyan Cao
    ,
    Robert T. Dura
    ,
    Robert M. Fettman
    ,
    Caroline P. Geiger
    ,
    Andrew J. Gershon
    ,
    Jin-Hyuk Jang
    ,
    Stuart Hammer
    ,
    Kim T. Le
    ,
    Michael P. McGuigan
    ,
    Sheena Paul
    ,
    Tricia Bozyk Sherno
    ,
    Jennifer Wheater
    ,
    John Young
    ,
    Jeffrey P. Cunard
    ,
    Ulysses Smith
    ,
    Jennifer R. Cestaro
    ,
    Paul Eastham
    ,
    Isabel Espinosa de los Reyes
    ,
    Jay E. Evans
    ,
    Christopher Gossage
    ,
    Berk Guler
    ,
    Yiran Ji
    ,
    Samuel D. Krawiecz
    ,
    Chaim Lapp
    ,
    Stacy S. Lee
    ,
    Lucy Litt
    ,
    Emily MacKay
    ,
    Alma M. Mozetič
    ,
    Ezra Newman
    ,
    Melissa Runsten
    ,
    Sergio Torres
    ,
    George Tan
    ,
    Tiffany Wu
    ,
    Emma Macfarlane
    ,
    Sarah Min
    ,
    Matthew Stromecki
    ,
    Massy Vainshtein
  • Practising Law Institute: Privacy Law Answer Book
    23 January 2023
    Luke Dembosky
    ,
    Avi Gesser
    ,
    Jyotin Hamid
    ,
    Satish M. Kini
    ,
    Henry Lebowitz
    ,
    Erez Liebermann
    ,
    Maura Kathleen Monaghan
    ,
    David A. O'Neil
    ,
    Jim Pastore
    ,
    David Sarratt
    ,
    Jeffrey P. Cunard
    ,
    Kim T. Le
    ,
    Tricia Bozyk Sherno
    ,
    Johanna N. Skrzypczyk
    ,
    Michael Bloom
    ,
    Fanny Gauthier
    ,
    Corey Jeremy Goldstein
    ,
    Hannah R. Levine
    ,
    Linda Lin
    ,
    Melissa Muse
    ,
    Kate Saba
    ,
    Noah L. Schwartz
    ,
    Mengyi Xu
  • Top 15 Healthcare and Life Sciences Issues to Watch in 2023
    9 January 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Michael Schaper
    ,
    Erica S. Weisgerber
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Elie J. Worenklein
    ,
    Samuel J. Allaman
    ,
    Adam Aukland-Peck
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
    ,
    Adam C. Saunders
    ,
    Adrian St. Francis
    ,
    Emily G. Dennan
    ,
    Michael L. Cederblom
    ,
    Micah A. Rubin
  • Implications of the Inflation Reduction Act for Investors in Life Sciences Companies
    November 2022
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Hannah R. Levine
    ,
    Michael L. Cederblom
  • Private Equity Report Fall 2022, Vol 22, No 3
    November 2022
    Andrew L. Bab
    ,
    Sally Bergmann Hardesty
    ,
    Michael Bolotin
    ,
    Jennifer L. Chu
    ,
    Erin Cleary
    ,
    Matthew Dickman
    ,
    Gregory V. Gooding
    ,
    Mark P. Goodman
    ,
    Gareth Hughes
    ,
    Mark Johnson
    ,
    Meir D. Katz
    ,
    Henry Lebowitz
    ,
    Maurizio Levi-Minzi
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kevin M. Schmidt
    ,
    Scott B. Selinger
    ,
    Ramya S. Tiller
    ,
    Zhiyan Cao
    ,
    Caroline P. Geiger
    ,
    Kim T. Le
    ,
    Jin-Hyuk Jang
    ,
    David Deutsch
    ,
    Tigist Kassahun
    ,
    Hannah R. Levine
    ,
    Keith J. Slattery
    ,
    Sergio Torres
    ,
    Dominique Trudelle
    ,
    Hadel Alfagir
    ,
    Michael L. Cederblom
    ,
    David N. Simpser
  • Dealmaking Implications of California’s New Healthcare Cost Monitoring Law
    19 August 2022
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Hannah R. Levine
  • Recent SCOTUS Decisions Impacting Healthcare
    3 August 2022
    Andrew L. Bab
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
  • FTC Sharpens Focus on Private Equity
    17 June 2022
    Andrew L. Bab
    ,
    Mark P. Goodman
    ,
    Ted Hassi
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Michael Schaper
    ,
    Erica S. Weisgerber
    ,
    Kim T. Le
    ,
    Leah Martin
    ,
    Adam C. Saunders
  • California Poised to Grant Attorney General Broad Approval Authority over Healthcare Transactions
    16 June 2022
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Hannah R. Levine
  • Texas Federal Judge Sides with Providers in “No Surprises Act” Ruling
    1 March 2022
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Adriana Kranjac
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
  • 2021/2022 Private Equity Year-End Review and Outlook
    January 2022
    Jonathan Adler
    ,
    Catherine Amirfar
    ,
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Andrew L. Bab
    ,
    Geoffrey P. Burgess
    ,
    Ezra Borut
    ,
    Andrew J. Ceresney
    ,
    Jennifer L. Chu
    ,
    Jeffrey P. Cunard
    ,
    Alexander R. Cochran
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Morgan J. Hayes
    ,
    Eric T. Juergens
    ,
    Maurizio Levi-Minzi
    ,
    Nicholas P. Pellicani
    ,
    Ryan T. Rafferty
    ,
    Julie M. Riewe
    ,
    Scott B. Selinger
    ,
    Marc Ponchione
    ,
    Thomas Smith
    ,
    Ramya S. Tiller
    ,
    Patricia Volhard
    ,
    Richard Ward
    ,
    Alisa A. Waxman
    ,
    Marshal L. Bozzo
    ,
    Christopher Dortschy
    ,
    Andrew J. Gershon
    ,
    Emily F. Huang
    ,
    Jennifer Wheater
    ,
    Dominic Blaxill
    ,
    Charles Cartiglia
    ,
    Robert T. Dura
    ,
    Matthew J. Sacco
    ,
    Sheng Shao
    ,
    Sergio Torres
    ,
    Charlotte A. Walkovik
    ,
    Paul Eastham
    ,
    Christopher Gossage
    ,
    Robert B. Kaplan
    ,
    Sheena Paul
    ,
    John Young
    ,
    Jin-Hyuk Jang
    ,
    Lukas Ott
    ,
    Andrew M. Levine
    ,
    Stuart Hammer
    ,
    Ulysses Smith
    ,
    Luke Dembosky
    ,
    Avi Gesser
    ,
    Peter J. Irwin
    ,
    Ina C. Popova
    ,
    Samantha J. Rowe
    ,
    M. Natasha Labovitz
    ,
    Sidney P. Levinson
    ,
    Paul D. Rubin
    ,
    Eric Dinallo
    ,
    Marilyn A. Lion
    ,
    Jacob W. Stahl
    ,
    Nicholas F. Potter
    ,
    Kim T. Le
    ,
    Adam Aukland-Peck
    ,
    Melissa Runsten
    ,
    Matthew Mrozek
    ,
    Michael C. Godbe
    ,
    Christel Y. Tham
    ,
    Lisa Wang Lachowicz
    ,
    Yiran Ji
  • CLS Blue Sky Blog: Debevoise & Plimpton Discusses New Privacy Legislation in the U.S.: The Patchwork Problem Grows
    26 July 2021
    CLS Blue Sky Blog
    Johanna N. Skrzypczyk
    ,
    Kim T. Le
    ,
    H Jacqueline Brehmer
  • 2021 Private Equity Midyear Review and Outlook
    22 July 2021
    Jonathan Adler
    ,
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Andrew L. Bab
    ,
    Megan K. Bannigan
    ,
    Sally Bergmann Hardesty
    ,
    David H. Bernstein
    ,
    Paul S. Bird
    ,
    Ezra Borut
    ,
    Geoffrey P. Burgess
    ,
    Jennifer L. Chu
    ,
    Matthew Dickman
    ,
    Christopher Dortschy
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Peter A. Furci
    ,
    Avi Gesser
    ,
    Jyotin Hamid
    ,
    Morgan J. Hayes
    ,
    Peter J. Irwin
    ,
    Meir D. Katz
    ,
    Rafael Kariyev
    ,
    M. Natasha Labovitz
    ,
    Maurizio Levi-Minzi
    ,
    Andrew M. Levine
    ,
    Sidney P. Levinson
    ,
    Jonathan F. Lewis
    ,
    Marc Ponchione
    ,
    Ryan T. Rafferty
    ,
    Paul D. Rubin
    ,
    Zachary H. Saltzman
    ,
    Kevin M. Schmidt
    ,
    Shannon Rose Selden
    ,
    Scott B. Selinger
    ,
    Steven J. Slutzky
    ,
    Ramya S. Tiller
    ,
    Richard Ward
    ,
    Alisa A. Waxman
    ,
    Patricia Volhard
    ,
    Franci J. Blassberg
    ,
    Jeffrey P. Cunard
    ,
    Andrew J. Gershon
    ,
    Stuart Hammer
    ,
    Jin-Hyuk Jang
    ,
    Kim T. Le
    ,
    Sheena Paul
    ,
    Tricia Bozyk Sherno
    ,
    Jacob W. Stahl
    ,
    Jennifer Wheater
    ,
    John Young
    ,
    Adam Aukland-Peck
    ,
    Dominic Blaxill
    ,
    Charles Cartiglia
    ,
    Robert T. Dura
    ,
    Paul Eastham
    ,
    Jay E. Evans
    ,
    Norma Angelica Lopez Campos
    ,
    David J. Hotelling
    ,
    Samuel D. Krawiecz
    ,
    Wen-Wei Lai
    ,
    Robert Maddox
    ,
    Sergio Torres
    ,
    Malina Welman
  • The American Rescue Plan Act of 2021: Implications for Healthcare and Life Sciences Companies
    12 March 2021
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
    ,
    Benjamin Leb
  • Proposed Elimination of Medicaid Rebate Cap Could Negatively Impact Innovator Pharmaceutical Industry
    11 February 2021
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • Biden Takes Aim at Trump Administration Healthcare Policies
    2 February 2021
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • 2020/2021 Private Equity Year End Review and Outlook
    7 January 2021
    Jonathan Adler
    ,
    William D. Regner
    ,
    John W. Rife III
    ,
    Alisa A. Waxman
    ,
    Jennifer R. Cestaro
    ,
    Katherine Ashton
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Thomas Smith
    ,
    Ramya S. Tiller
    ,
    Christopher Anthony
    ,
    Kevin M. Schmidt
    ,
    Maurizio Levi-Minzi
    ,
    Geoffrey P. Burgess
    ,
    Dominic Blaxill
    ,
    Wen-Wei Lai
    ,
    Jyotin Hamid
    ,
    Morgan J. Hayes
    ,
    Steven J. Slutzky
    ,
    Richard Ward
    ,
    Jennifer Wheater
    ,
    Paul Eastham
    ,
    Peter A. Furci
    ,
    Rafael Kariyev
    ,
    Jay E. Evans
    ,
    Samuel D. Krawiecz
    ,
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Jyotin Hamid
    ,
    Meir D. Katz
    ,
    Jonathan F. Lewis
    ,
    Tricia Bozyk Sherno
    ,
    Ezra Borut
    ,
    Jeffrey P. Cunard
    ,
    Marc Ponchione
    ,
    Kenneth J. Berman
    ,
    Norma Angelica Lopez Campos
    ,
    Patricia Volhard
    ,
    Christopher Dortschy
    ,
    Jin-Hyuk Jang
    ,
    John Young
    ,
    Andrew J. Ceresney
    ,
    Robert B. Kaplan
    ,
    Julie M. Riewe
    ,
    Sally Bergmann Hardesty
    ,
    Scott B. Selinger
    ,
    Stuart Hammer
    ,
    Luke Dembosky
    ,
    Avi Gesser
    ,
    Jim Pastore
    ,
    Megan K. Bannigan
    ,
    David H. Bernstein
    ,
    M. Natasha Labovitz
    ,
    Sidney P. Levinson
    ,
    Peter J. Irwin
    ,
    Malina Welman
    ,
    Paul S. Bird
  • Consolidated Appropriations Act: Implications for Healthcare and Life Sciences Companies
    30 December 2020
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kristin D. Kiehn
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • The Trump Administration’s Final Drug Pricing Hurrah—Will It Last?
    24 November 2020
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • Federal Government Shines Spotlight on Speaker Programs
    20 November 2020
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Paul D. Rubin
    ,
    Kristin D. Kiehn
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • The Potential Impact of a Biden Administration on Life Sciences, Healthcare, and Consumer Product Companies and Investors
    2 November 2020
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Maura Kathleen Monaghan
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • Providers, Investors Need Clear Post-COVID Telehealth Picture
    22 September 2020
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • Bloomberg Law: Providers, Investors Need Clear Post-Covid Telehealth Picture
    16 September 2020
    Bloomberg Law
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Melissa Runsten
    ,
    Kim T. Le
  • Bloomberg Law: Providers, Investors Need Clear Post-Covid Telehealth Picture
    16 September 2020
    Bloomberg Law
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Melissa Runsten
    ,
    Kim T. Le
  • Trump’s Newest Drug Pricing Executive Order: Still Much More Bark than Bite
    16 September 2020
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten
  • HHS Announces Additional CARES Act Funding for Qualifying Providers
    4 August 2020
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Kim T. Le
    ,
    Melissa Runsten

Upcoming Events

Recent Events

  • From Primary to Secondary use of Health Personal Data, from Open Data to Intellectual Property Investment Protection: is Privacy Opposed to Data Valuation?
    31 May - 2 June 2023
    International Bar Association
    9th Annual IBA World Life Sciences Conference
    Washington, DC
    Speaker: Kim T. Le
    Speaking Engagements
  • Key Transactional, Legal & Regulatory Developments for Healthcare Investors
    3 February 2022
    Debevoise & Plimpton LLP
    Webcast
    Speaking Engagements